Final answer:
Antihypertensives are rarely given for preeclampsia due to the risk of fetal hypotension, limited efficacy in treating the underlying condition, and the potential for causing maternal hypotension. Other risks include fetal renal failure and cranial bone abnormalities from specific drugs like ACE inhibitors.
Step-by-step explanation:
The question asks why antihypertensives are rarely given for a client with preeclampsia. The correct answer is d) All of the above, which includes the risk of fetal hypotension, limited efficacy, and the potential for maternal hypotension. Preeclampsia is a complex condition, and while managing blood pressure is important, the focus is often on balancing the risks and benefits to both the mother and the fetus.
Antihypertensive drugs like Angiotensin Converting Enzyme (ACE) inhibitors are avoided because they can cause serious fetal complications, such as fetal renal failure, oligohydramnios leading to pulmonary hypoplasia, limb contractures, and cranial bone abnormalities.
Therefore, the management of preeclampsia typically involves close monitoring and addressing the underlying condition rather than primary reliance on antihypertensive medications.